Global Nuclear Medicine Isotopes Market Size, Status And Forecast 2021-2027

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Isotopes Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Stable Isotopes
1.2.3 Radioisotopes
1.3 Market by Application
1.3.1 Global Nuclear Medicine Isotopes Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Nuclear Therapy
1.3.3 Equipment Radioactive Source
1.3.4 Diagnosis
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nuclear Medicine Isotopes Market Perspective (2016-2027)
2.2 Nuclear Medicine Isotopes Growth Trends by Regions
2.2.1 Nuclear Medicine Isotopes Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nuclear Medicine Isotopes Historic Market Share by Regions (2016-2021)
2.2.3 Nuclear Medicine Isotopes Forecasted Market Size by Regions (2022-2027)
2.3 Nuclear Medicine Isotopes Industry Dynamic
2.3.1 Nuclear Medicine Isotopes Market Trends
2.3.2 Nuclear Medicine Isotopes Market Drivers
2.3.3 Nuclear Medicine Isotopes Market Challenges
2.3.4 Nuclear Medicine Isotopes Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Isotopes Players by Revenue
3.1.1 Global Top Nuclear Medicine Isotopes Players by Revenue (2016-2021)
3.1.2 Global Nuclear Medicine Isotopes Revenue Market Share by Players (2016-2021)
3.2 Global Nuclear Medicine Isotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nuclear Medicine Isotopes Revenue
3.4 Global Nuclear Medicine Isotopes Market Concentration Ratio
3.4.1 Global Nuclear Medicine Isotopes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Isotopes Revenue in 2020
3.5 Nuclear Medicine Isotopes Key Players Head office and Area Served
3.6 Key Players Nuclear Medicine Isotopes Product Solution and Service
3.7 Date of Enter into Nuclear Medicine Isotopes Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nuclear Medicine Isotopes Breakdown Data by Type
4.1 Global Nuclear Medicine Isotopes Historic Market Size by Type (2016-2021)
4.2 Global Nuclear Medicine Isotopes Forecasted Market Size by Type (2022-2027)

5 Nuclear Medicine Isotopes Breakdown Data by Application
5.1 Global Nuclear Medicine Isotopes Historic Market Size by Application (2016-2021)
5.2 Global Nuclear Medicine Isotopes Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nuclear Medicine Isotopes Market Size (2016-2027)
6.2 North America Nuclear Medicine Isotopes Market Size by Type
6.2.1 North America Nuclear Medicine Isotopes Market Size by Type (2016-2021)
6.2.2 North America Nuclear Medicine Isotopes Market Size by Type (2022-2027)
6.2.3 North America Nuclear Medicine Isotopes Market Size by Type (2016-2027)
6.3 North America Nuclear Medicine Isotopes Market Size by Application
6.3.1 North America Nuclear Medicine Isotopes Market Size by Application (2016-2021)
6.3.2 North America Nuclear Medicine Isotopes Market Size by Application (2022-2027)
6.3.3 North America Nuclear Medicine Isotopes Market Size by Application (2016-2027)
6.4 North America Nuclear Medicine Isotopes Market Size by Country
6.4.1 North America Nuclear Medicine Isotopes Market Size by Country (2016-2021)
6.4.2 North America Nuclear Medicine Isotopes Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Nuclear Medicine Isotopes Market Size (2016-2027)
7.2 Europe Nuclear Medicine Isotopes Market Size by Type
7.2.1 Europe Nuclear Medicine Isotopes Market Size by Type (2016-2021)
7.2.2 Europe Nuclear Medicine Isotopes Market Size by Type (2022-2027)
7.2.3 Europe Nuclear Medicine Isotopes Market Size by Type (2016-2027)
7.3 Europe Nuclear Medicine Isotopes Market Size by Application
7.3.1 Europe Nuclear Medicine Isotopes Market Size by Application (2016-2021)
7.3.2 Europe Nuclear Medicine Isotopes Market Size by Application (2022-2027)
7.3.3 Europe Nuclear Medicine Isotopes Market Size by Application (2016-2027)
7.4 Europe Nuclear Medicine Isotopes Market Size by Country
7.4.1 Europe Nuclear Medicine Isotopes Market Size by Country (2016-2021)
7.4.2 Europe Nuclear Medicine Isotopes Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Isotopes Market Size (2016-2027)
8.2 Asia-Pacific Nuclear Medicine Isotopes Market Size by Type
8.2.1 Asia-Pacific Nuclear Medicine Isotopes Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nuclear Medicine Isotopes Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nuclear Medicine Isotopes Market Size by Type (2016-2027)
8.3 Asia-Pacific Nuclear Medicine Isotopes Market Size by Application
8.3.1 Asia-Pacific Nuclear Medicine Isotopes Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nuclear Medicine Isotopes Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nuclear Medicine Isotopes Market Size by Application (2016-2027)
8.4 Asia-Pacific Nuclear Medicine Isotopes Market Size by Region
8.4.1 Asia-Pacific Nuclear Medicine Isotopes Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nuclear Medicine Isotopes Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nuclear Medicine Isotopes Market Size (2016-2027)
9.2 Latin America Nuclear Medicine Isotopes Market Size by Type
9.2.1 Latin America Nuclear Medicine Isotopes Market Size by Type (2016-2021)
9.2.2 Latin America Nuclear Medicine Isotopes Market Size by Type (2022-2027)
9.2.3 Latin America Nuclear Medicine Isotopes Market Size by Type (2016-2027)
9.3 Latin America Nuclear Medicine Isotopes Market Size by Application
9.3.1 Latin America Nuclear Medicine Isotopes Market Size by Application (2016-2021)
9.3.2 Latin America Nuclear Medicine Isotopes Market Size by Application (2022-2027)
9.3.3 Latin America Nuclear Medicine Isotopes Market Size by Application (2016-2027)
9.4 Latin America Nuclear Medicine Isotopes Market Size by Country
9.4.1 Latin America Nuclear Medicine Isotopes Market Size by Country (2016-2021)
9.4.2 Latin America Nuclear Medicine Isotopes Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Isotopes Market Size (2016-2027)
10.2 Middle East & Africa Nuclear Medicine Isotopes Market Size by Type
10.2.1 Middle East & Africa Nuclear Medicine Isotopes Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nuclear Medicine Isotopes Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nuclear Medicine Isotopes Market Size by Type (2016-2027)
10.3 Middle East & Africa Nuclear Medicine Isotopes Market Size by Application
10.3.1 Middle East & Africa Nuclear Medicine Isotopes Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nuclear Medicine Isotopes Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nuclear Medicine Isotopes Market Size by Application (2016-2027)
10.4 Middle East & Africa Nuclear Medicine Isotopes Market Size by Country
10.4.1 Middle East & Africa Nuclear Medicine Isotopes Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nuclear Medicine Isotopes Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 NRG
11.1.1 NRG Company Details
11.1.2 NRG Business Overview
11.1.3 NRG Nuclear Medicine Isotopes Introduction
11.1.4 NRG Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.1.5 NRG Recent Development
11.2 NTP Radioisotopes
11.2.1 NTP Radioisotopes Company Details
11.2.2 NTP Radioisotopes Business Overview
11.2.3 NTP Radioisotopes Nuclear Medicine Isotopes Introduction
11.2.4 NTP Radioisotopes Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.2.5 NTP Radioisotopes Recent Development
11.3 JSC Isotope
11.3.1 JSC Isotope Company Details
11.3.2 JSC Isotope Business Overview
11.3.3 JSC Isotope Nuclear Medicine Isotopes Introduction
11.3.4 JSC Isotope Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.3.5 JSC Isotope Recent Development
11.4 ANSTO
11.4.1 ANSTO Company Details
11.4.2 ANSTO Business Overview
11.4.3 ANSTO Nuclear Medicine Isotopes Introduction
11.4.4 ANSTO Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.4.5 ANSTO Recent Development
11.5 IRE
11.5.1 IRE Company Details
11.5.2 IRE Business Overview
11.5.3 IRE Nuclear Medicine Isotopes Introduction
11.5.4 IRE Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.5.5 IRE Recent Development
11.6 Nordion
11.6.1 Nordion Company Details
11.6.2 Nordion Business Overview
11.6.3 Nordion Nuclear Medicine Isotopes Introduction
11.6.4 Nordion Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.6.5 Nordion Recent Development
11.7 Curium Pharma
11.7.1 Curium Pharma Company Details
11.7.2 Curium Pharma Business Overview
11.7.3 Curium Pharma Nuclear Medicine Isotopes Introduction
11.7.4 Curium Pharma Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.7.5 Curium Pharma Recent Development
11.8 Cambridge Isotope Laboratories
11.8.1 Cambridge Isotope Laboratories Company Details
11.8.2 Cambridge Isotope Laboratories Business Overview
11.8.3 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Introduction
11.8.4 Cambridge Isotope Laboratories Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.8.5 Cambridge Isotope Laboratories Recent Development
11.9 Eckert & Ziegler Strahlen
11.9.1 Eckert & Ziegler Strahlen Company Details
11.9.2 Eckert & Ziegler Strahlen Business Overview
11.9.3 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Introduction
11.9.4 Eckert & Ziegler Strahlen Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.9.5 Eckert & Ziegler Strahlen Recent Development
11.10 Polatom
11.10.1 Polatom Company Details
11.10.2 Polatom Business Overview
11.10.3 Polatom Nuclear Medicine Isotopes Introduction
11.10.4 Polatom Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.10.5 Polatom Recent Development
11.11 Center of Molecular Research
11.11.1 Center of Molecular Research Company Details
11.11.2 Center of Molecular Research Business Overview
11.11.3 Center of Molecular Research Nuclear Medicine Isotopes Introduction
11.11.4 Center of Molecular Research Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.11.5 Center of Molecular Research Recent Development
11.12 China National Nuclear Corporation
11.12.1 China National Nuclear Corporation Company Details
11.12.2 China National Nuclear Corporation Business Overview
11.12.3 China National Nuclear Corporation Nuclear Medicine Isotopes Introduction
11.12.4 China National Nuclear Corporation Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.12.5 China National Nuclear Corporation Recent Development
11.13 Urenco
11.13.1 Urenco Company Details
11.13.2 Urenco Business Overview
11.13.3 Urenco Nuclear Medicine Isotopes Introduction
11.13.4 Urenco Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.13.5 Urenco Recent Development
11.14 LANL
11.14.1 LANL Company Details
11.14.2 LANL Business Overview
11.14.3 LANL Nuclear Medicine Isotopes Introduction
11.14.4 LANL Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.14.5 LANL Recent Development
11.15 Shanghai Engineering Research Center
11.15.1 Shanghai Engineering Research Center Company Details
11.15.2 Shanghai Engineering Research Center Business Overview
11.15.3 Shanghai Engineering Research Center Nuclear Medicine Isotopes Introduction
11.15.4 Shanghai Engineering Research Center Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.15.5 Shanghai Engineering Research Center Recent Development
11.16 IDB Holland
11.16.1 IDB Holland Company Details
11.16.2 IDB Holland Business Overview
11.16.3 IDB Holland Nuclear Medicine Isotopes Introduction
11.16.4 IDB Holland Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.16.5 IDB Holland Recent Development
11.17 NHTC
11.17.1 NHTC Company Details
11.17.2 NHTC Business Overview
11.17.3 NHTC Nuclear Medicine Isotopes Introduction
11.17.4 NHTC Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.17.5 NHTC Recent Development
11.18 Linde
11.18.1 Linde Company Details
11.18.2 Linde Business Overview
11.18.3 Linde Nuclear Medicine Isotopes Introduction
11.18.4 Linde Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.18.5 Linde Recent Development
11.18 ORNL
.1 ORNL Company Details
.2 ORNL Business Overview
.3 ORNL Nuclear Medicine Isotopes Introduction
.4 ORNL Revenue in Nuclear Medicine Isotopes Business (2016-2021)
.5 ORNL Recent Development
11.20 SI Science
11.20.1 SI Science Company Details
11.20.2 SI Science Business Overview
11.20.3 SI Science Nuclear Medicine Isotopes Introduction
11.20.4 SI Science Revenue in Nuclear Medicine Isotopes Business (2016-2021)
11.20.5 SI Science Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nuclear Medicine Isotopes Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Stable Isotopes
Table 3. Key Players of Radioisotopes
Table 4. Global Nuclear Medicine Isotopes Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Nuclear Medicine Isotopes Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Nuclear Medicine Isotopes Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Nuclear Medicine Isotopes Market Share by Regions (2016-2021)
Table 8. Global Nuclear Medicine Isotopes Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Nuclear Medicine Isotopes Market Share by Regions (2022-2027)
Table 10. Nuclear Medicine Isotopes Market Trends
Table 11. Nuclear Medicine Isotopes Market Drivers
Table 12. Nuclear Medicine Isotopes Market Challenges
Table 13. Nuclear Medicine Isotopes Market Restraints
Table 14. Global Nuclear Medicine Isotopes Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Nuclear Medicine Isotopes Market Share by Players (2016-2021)
Table 16. Global Top Nuclear Medicine Isotopes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine Isotopes as of 2020)
Table 17. Ranking of Global Top Nuclear Medicine Isotopes Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Nuclear Medicine Isotopes Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Nuclear Medicine Isotopes Product Solution and Service
Table 21. Date of Enter into Nuclear Medicine Isotopes Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nuclear Medicine Isotopes Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Nuclear Medicine Isotopes Revenue Market Share by Type (2016-2021)
Table 25. Global Nuclear Medicine Isotopes Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Nuclear Medicine Isotopes Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Nuclear Medicine Isotopes Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Nuclear Medicine Isotopes Revenue Market Share by Application (2016-2021)
Table 29. Global Nuclear Medicine Isotopes Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Nuclear Medicine Isotopes Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Nuclear Medicine Isotopes Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Nuclear Medicine Isotopes Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Nuclear Medicine Isotopes Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Nuclear Medicine Isotopes Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Nuclear Medicine Isotopes Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Nuclear Medicine Isotopes Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Nuclear Medicine Isotopes Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Nuclear Medicine Isotopes Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Nuclear Medicine Isotopes Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Nuclear Medicine Isotopes Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Nuclear Medicine Isotopes Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Nuclear Medicine Isotopes Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Nuclear Medicine Isotopes Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Nuclear Medicine Isotopes Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Nuclear Medicine Isotopes Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Nuclear Medicine Isotopes Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Nuclear Medicine Isotopes Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Nuclear Medicine Isotopes Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Nuclear Medicine Isotopes Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Nuclear Medicine Isotopes Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Nuclear Medicine Isotopes Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Nuclear Medicine Isotopes Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Nuclear Medicine Isotopes Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Nuclear Medicine Isotopes Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Nuclear Medicine Isotopes Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Nuclear Medicine Isotopes Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Nuclear Medicine Isotopes Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Nuclear Medicine Isotopes Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Nuclear Medicine Isotopes Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Nuclear Medicine Isotopes Market Size by Country (2022-2027) & (US$ Million)
Table 61. NRG Company Details
Table 62. NRG Business Overview
Table 63. NRG Nuclear Medicine Isotopes Product
Table 64. NRG Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 65. NRG Recent Development
Table 66. NTP Radioisotopes Company Details
Table 67. NTP Radioisotopes Business Overview
Table 68. NTP Radioisotopes Nuclear Medicine Isotopes Product
Table 69. NTP Radioisotopes Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 70. NTP Radioisotopes Recent Development
Table 71. JSC Isotope Company Details
Table 72. JSC Isotope Business Overview
Table 73. JSC Isotope Nuclear Medicine Isotopes Product
Table 74. JSC Isotope Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 75. JSC Isotope Recent Development
Table 76. ANSTO Company Details
Table 77. ANSTO Business Overview
Table 78. ANSTO Nuclear Medicine Isotopes Product
Table 79. ANSTO Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 80. ANSTO Recent Development
Table 81. IRE Company Details
Table 82. IRE Business Overview
Table 83. IRE Nuclear Medicine Isotopes Product
Table 84. IRE Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 85. IRE Recent Development
Table 86. Nordion Company Details
Table 87. Nordion Business Overview
Table 88. Nordion Nuclear Medicine Isotopes Product
Table 89. Nordion Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 90. Nordion Recent Development
Table 91. Curium Pharma Company Details
Table 92. Curium Pharma Business Overview
Table 93. Curium Pharma Nuclear Medicine Isotopes Product
Table 94. Curium Pharma Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 95. Curium Pharma Recent Development
Table 96. Cambridge Isotope Laboratories Company Details
Table 97. Cambridge Isotope Laboratories Business Overview
Table 98. Cambridge Isotope Laboratories Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 99. Cambridge Isotope Laboratories Recent Development
Table 100. Eckert & Ziegler Strahlen Company Details
Table 101. Eckert & Ziegler Strahlen Business Overview
Table 102. Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Product
Table 103. Eckert & Ziegler Strahlen Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 104. Eckert & Ziegler Strahlen Recent Development
Table 105. Polatom Company Details
Table 106. Polatom Business Overview
Table 107. Polatom Nuclear Medicine Isotopes Product
Table 108. Polatom Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 109. Polatom Recent Development
Table 110. Center of Molecular Research Company Details
Table 111. Center of Molecular Research Business Overview
Table 112. Center of Molecular Research Nuclear Medicine Isotopes Product
Table 113. Center of Molecular Research Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 114. Center of Molecular Research Recent Development
Table 115. China National Nuclear Corporation Company Details
Table 116. China National Nuclear Corporation Business Overview
Table 117. China National Nuclear Corporation Nuclear Medicine Isotopes Product
Table 118. China National Nuclear Corporation Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 119. China National Nuclear Corporation Recent Development
Table 120. Urenco Company Details
Table 121. Urenco Business Overview
Table 122. Urenco Nuclear Medicine Isotopes Product
Table 123. Urenco Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 124. Urenco Recent Development
Table 125. LANL Company Details
Table 126. LANL Business Overview
Table 127. LANL Nuclear Medicine Isotopes Product
Table 128. LANL Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 129. LANL Recent Development
Table 130. Shanghai Engineering Research Center Company Details
Table 131. Shanghai Engineering Research Center Business Overview
Table 132. Shanghai Engineering Research Center Nuclear Medicine Isotopes Product
Table 133. Shanghai Engineering Research Center Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 134. Shanghai Engineering Research Center Recent Development
Table 135. IDB Holland Company Details
Table 136. IDB Holland Business Overview
Table 137. IDB Holland Nuclear Medicine Isotopes Product
Table 138. IDB Holland Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 139. IDB Holland Recent Development
Table 140. NHTC Company Details
Table 141. NHTC Business Overview
Table 142. NHTC Nuclear Medicine Isotopes Product
Table 143. NHTC Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 144. NHTC Recent Development
Table 145. Linde Company Details
Table 146. Linde Business Overview
Table 147. Linde Nuclear Medicine Isotopes Product
Table 148. Linde Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 149. Linde Recent Development
Table 150. ORNL Company Details
Table 151. ORNL Business Overview
Table 152. ORNL Nuclear Medicine Isotopes Product
Table 153. ORNL Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 154. ORNL Recent Development
Table 155. SI Science Company Details
Table 156. SI Science Business Overview
Table 157. SI Science Nuclear Medicine Isotopes Product
Table 158. SI Science Revenue in Nuclear Medicine Isotopes Business (2016-2021) & (US$ Million)
Table 159. SI Science Recent Development
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclear Medicine Isotopes Market Share by Type: 2020 VS 2027
Figure 2. Stable Isotopes Features
Figure 3. Radioisotopes Features
Figure 4. Global Nuclear Medicine Isotopes Market Share by Application: 2020 VS 2027
Figure 5. Nuclear Therapy Case Studies
Figure 6. Equipment Radioactive Source Case Studies
Figure 7. Diagnosis Case Studies
Figure 8. Nuclear Medicine Isotopes Report Years Considered
Figure 9. Global Nuclear Medicine Isotopes Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Nuclear Medicine Isotopes Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Nuclear Medicine Isotopes Market Share by Regions: 2020 VS 2027
Figure 12. Global Nuclear Medicine Isotopes Market Share by Regions (2022-2027)
Figure 13. Global Nuclear Medicine Isotopes Market Share by Players in 2020
Figure 14. Global Top Nuclear Medicine Isotopes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine Isotopes as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Nuclear Medicine Isotopes Revenue in 2020
Figure 16. Global Nuclear Medicine Isotopes Revenue Market Share by Type (2016-2021)
Figure 17. Global Nuclear Medicine Isotopes Revenue Market Share by Type (2022-2027)
Figure 18. North America Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Nuclear Medicine Isotopes Market Share by Type (2016-2027)
Figure 20. North America Nuclear Medicine Isotopes Market Share by Application (2016-2027)
Figure 21. North America Nuclear Medicine Isotopes Market Share by Country (2016-2027)
Figure 22. United States Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Nuclear Medicine Isotopes Market Share by Type (2016-2027)
Figure 26. Europe Nuclear Medicine Isotopes Market Share by Application (2016-2027)
Figure 27. Europe Nuclear Medicine Isotopes Market Share by Country (2016-2027)
Figure 28. Germany Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Nuclear Medicine Isotopes Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Nuclear Medicine Isotopes Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Nuclear Medicine Isotopes Market Share by Region (2016-2027)
Figure 38. China Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Nuclear Medicine Isotopes Market Share by Type (2016-2027)
Figure 46. Latin America Nuclear Medicine Isotopes Market Share by Application (2016-2027)
Figure 47. Latin America Nuclear Medicine Isotopes Market Share by Country (2016-2027)
Figure 48. Mexico Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Nuclear Medicine Isotopes Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Nuclear Medicine Isotopes Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Nuclear Medicine Isotopes Market Share by Country (2016-2027)
Figure 54. Turkey Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Nuclear Medicine Isotopes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. NRG Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 58. NTP Radioisotopes Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 59. JSC Isotope Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 60. ANSTO Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 61. IRE Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 62. Nordion Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 63. Curium Pharma Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 64. Cambridge Isotope Laboratories Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 65. Eckert & Ziegler Strahlen Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 66. Polatom Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 67. Center of Molecular Research Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 68. China National Nuclear Corporation Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 69. Urenco Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 70. LANL Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 71. Shanghai Engineering Research Center Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 72. IDB Holland Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 73. NHTC Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 74. Linde Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 75. ORNL Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 76. SI Science Revenue Growth Rate in Nuclear Medicine Isotopes Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.